[go: up one dir, main page]

Sumi et al., 1982 - Google Patents

Higher fibrin-binding and thrombolytic properties of single polypeptide chain-high molecular weight urokinase

Sumi et al., 1982

Document ID
3332444949789366307
Author
Sumi H
Maruyama M
Matsuo O
Mihara H
Toki N
Publication year
Publication venue
Thrombosis and haemostasis

External Links

Snippet

Dear Sir, High molecular weight urokinase (HlvilV-UK) has been considered as the native enzyme in urine,@ Dprising a two polypeptide chain molecule@ nnected by one interchain disulfide bond, while low molecular weight urokinase (LtvfW-LJK) represents an enzy …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases Endopeptidases (3.4.21-3.4.25) derived from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Similar Documents

Publication Publication Date Title
Sumi et al. Higher fibrin-binding and thrombolytic properties of single polypeptide chain-high molecular weight urokinase
Esmon et al. Protein C activation
DE3687584T4 (en) Vectors and methods for expressing a substance containing the activity of human protein-C.
EP0217379B1 (en) Thrombolytic composition and a process for production thereof
US4970159A (en) Human tissue plasminogen activator consisting essentially of t-PA residues 160 to 527
DE3316297A1 (en) HUMAN TISSUE PLASMINOGEN ACTIVATOR
ATE279430T1 (en) METHOD FOR IMPROVING THE SERUM HALF-LIFE OF BIOLOGICALLY ACTIVE MOLECULES
EP0575054A2 (en) Protein C derivatives
JPH0729937B2 (en) Inhibition of tumor growth by blocking the protein C system
Lijnen et al. Mechanisms of plasminogen activation by mammalian plasminogen activators
Verstraete The fibrinolytic system: from Petri dishes to genetic engineering
US4857320A (en) Method of enhancing the solubility of tissue plasminogen activator
Marie-Claude Effect of rabbit thrombomodulin on thrombin inhibition by antithrombin in the presence of heparin
Livingstone et al. The purification and preliminary characterization of UMP synthase from human placenta.
US20210062175A1 (en) Fibrinolytic enzyme from agrocybe aegerita and a preparation method thereof
US6706504B1 (en) Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
EP0666920B1 (en) Thrombin activatable plasminogen derivatives
WO1998021320A9 (en) TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
EP0950095A2 (en) TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
EP0247674B1 (en) Plasminogen activator and thrombolytic composition
Fiddler et al. Enzyme therapy: Differential in vivo retention of bovine hepatic, renal, and splenic β-glucuronidases and evidence for enzyme stabilization by intermolecular exchange
Bode et al. Future directions in plasminogen activator therapy
WO1992002612A3 (en) Tissue plasminogen activator variants with decreased clearance
Loscalzo Molecular biologic modification of plasminogen activators. An artful science.
EP0917567A1 (en) Plasminogen activator capable of being activated by thrombin